|
|||||
|
|
| 西地那非抗ED治疗的临床研究 | |
| 引用本文： | 黄寿吾,崔以泰. 西地那非抗ED治疗的临床研究[J]. 中国性科学, 2007, 16(11): 3-6 |
| 作者姓名： | 黄寿吾 崔以泰 |
| 作者单位： | 1. 河南科技大学第一附属医院,河南,洛阳,471003 2. 天津医科大学,天津,300070 |
| 摘 要： | 西地那非(Sil)作为第一个口服抗勃起障碍(ED)药物问世以来,从基础到临床进行了广泛的研究,成果丰硕。循证医学资料表明,Sil治疗ED具有良好的安全性、耐受性,有效率达80%以上,对不同病因和多种伴发疾病以及并用除硝酸类外药物的ED患者均有显著疗效。本文还对Sil长期服用的可行性进行了评述。 |
| 关 键 词： | 西地那非 勃起障碍 |
| 修稿时间： | 2007-08-22 |
An update on the clinical application of sildenafil for erectile dysfunction |
|
| HUANG Shouwu,CUI Yitai. An update on the clinical application of sildenafil for erectile dysfunction[J]. The Chinese Journal of Human Sexuality, 2007, 16(11): 3-6 | |
| Authors: | HUANG Shouwu CUI Yitai |
| Abstract: | Since sildenafil(Sil) was marketed as the first oral drug for the treatment for erectile dysfunction(ED),much achivements were available from in vitro experiments and clinical trials.Clinical data from evidence-based medicine have confirmed that its use for ED was safe,tolerable and effective(effective rate:>80%),irrespective of varying etiologies and diverse comorbidities,or receiving concurrent combinations of other drugs but nitraties.In this review the feasibility of long-term use of Sil for ED is also discussed. |
| Keywords: | Sildenafil Erectile dysfunction |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ | |